News from NORD

Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone

Publish date: April 14, 2017

 

The Foundation for Prader-Willi Research has published a blog and brochure regarding recent findings related to use of growth hormone for those affected by Prader-Willi syndrome.

Recommended Reading

Anthony Fauci faces the ‘perpetual challenge’ of emerging infections
MDedge Neurology
FDA approves deutetrabenazine for Huntington’s-associated chorea
MDedge Neurology
FDA approves first home genetic health risk test
MDedge Neurology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Neurology
NORD and Neurology Reviews Publish Special Report
MDedge Neurology
Save the Date for the 2017 NORD Summit
MDedge Neurology
Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Neurology
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Neurology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Neurology
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Neurology